Address And Details

1295 State St , Springfield, MA 01111
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

This Fund seeks to achieve a high total rate of return primarily from current income while minimizing fluctuations in capital values by investing primarily in a diversified portfolio of short-term investment grade fixed income securities.Under normal circumstances,the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in investment grade fixed income securities (rated Baa3 or higher by Moody’s, BBB- or higher by Standard & Poor’s or the equivalent by any NRSRO,or,if unrated,determined to be of comparable quality by the subadviser).These typically include U.S.dollar-denominated corporate obligations,securities issued or guaranteed by the U.S.Government or its agencies or instrumentalities,U.S.and foreign issuer dollar-denominated bonds including,but not limited to,corporate obligations,government and agency issues,private placement bonds,securities or decrease its duration in response to changes in interest rates and other factors.Duration measures the price sensitivity of a bond to changes in interest rates.Duration is the dollar weighted average time to maturity of a bond utilizing the present value of all future cash flows.Barings generally selects the Fund’s investments based on its analysis of opportunities and risks of various securities and market sectors.Barings may choose to sell securities with deteriorating credit or limited upside potential compared to other available securities.The Fund expects that it will engage in active and frequent trading and so will typically have a relatively high portfolio turnover rate.

Net Asset Value

as of 5:49 PM ET 09/22/2021

Performance

  • 1 Week
  • +0.10%
  • 1 Month
  • +0.20%
  • 3 Months
  • +0.40%
  • 1 Yr Return
  • +0.20%
  • 5 Yr Return
  • -2.82%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 99.24%
Cash 1.31%
Stocks 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Other -0.55%
Total Net Assets 24.15 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.19 1.10 1.01
Beta 0.20 0.19 0.21
R Squared 0.02 0.03 0.06
Std Deviation 4.65 3.61 2.63
Sharpe Ratio 0.44 0.41 n/a

Purchase Information

as of 5:39 PM ET 09/15/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 05/31/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 05/31/2021
1 Year
  • +4.93%
  • +9.93%
+4.93% +9.93%
3 Year
  • +3.02%
  • +3.09%
+3.02% +3.09%
10 Year
  • +2.12%
  • +2.15%
+2.12% +2.15%
Life Of Fund
  • +3.59%
  • +3.61%
+3.59% +3.61%

Top 10 Holdings

Symbol Company Name % Of Assets
n/a

Recent Articles from TheStreet

Jim Cramer: Darden Buying Cheddar Shows Me There's Growth in Restaurants

Premarket Movers Thursday - Darden, Salesforce, Biogen, BlackBerry

Stocks moving in premarket trading Thursday include Biogen, BlackBerry, Apple, Darden Restaurants and Salesforce.com.

Salesforce Lead

Salesforce Stock Gains On 2022 Revenue Forecast Boost Ahead of Investor Day

Salesforce nudged its 2022 revenue forecast to between $26.25 billion to $26.356 billion ahead of an investor day presentation in San Francisco.

NYSE Lead

Stock Futures Extend Gains On Fed Taper Patience, Evergrande Debt Payment In Focus

The Fed's patient stance on tapering, and cautious optimism for a brokered solution to China Evergrande's debt crisis, has Wall Street futures moving higher Thursday.

Pfizer vaccine Lead

Pfizer Stock Higher As FDA Clears COVID Booster Shots For Older And At-Risk Americans

The FDA said older and at-risk Americans can receive a third 'booster' shot of Pfizer's COVID vaccine six months after their second.

boeing (2)

Boeing Stock Gains After China Demand Forecast Boosted To $1.5 Trillion

Boeing said Thursday that China will need around $1.5 trillion worth of new aircraft over the next 20 years, while spending a further $1.8 trillion on services.

Wall Street Lead

Stocks Gain As Fed Waits On Tapering, Pfizer Gets FDA Boosters Nod - 5 Things You Must Know

Stock futures gain as Fed punts on taper; Powell says strong September jobs report could start ball rolling; Tech, auto bosses meet with White House on chip shortage; Boeing boosts China demand forecast and Pfizer gets FDA approval for COVID boosters.